Table 5.

Treatment of Manifestations in Individuals with ATR-X Syndrome

Manifestation/ConcernTreatmentConsiderations/Other
DD/ID See Developmental Delay / Intellectual Disability Management Issues.
Seizures Standardized treatment w/ASM by experienced neurologist
  • Many ASMs may be effective; none demonstrated effective specifically for this disorder
  • Education of parents/caregivers 1
Gastrointestinal/
Feeding
Feeding therapy; calorie-dense formula; gastrostomy tube placement as needed for persistent feeding issues
  • Usual treatment for GERD, constipation
  • Treatment for gastric pseudo-obstruction per treating gastroenterologist/pediatric surgeon
Drooling Anticholinergics, botulinum toxin type A injection of salivary glands &/or surgical redirecting of submandibular ductsOptions when drooling is a serious problem
Genital
abnormalities
Per treating urologist
Musculoskeletal Orthopedics / physical medicine & rehab / PT & OTUse of durable medical equipment & positioning devices as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers)
Congenital heart
defects
Per treating cardiologist
Ophthalmologic
involvement
Per treating ophthalmologist

ASM = anti-seizure medication; DD = developmental delay; ID = intellectual disability; OT = occupational therapy; PT = physical therapy

From: Alpha-Thalassemia X-Linked Intellectual Disability Syndrome

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.